Intranasal

India’s first intranasal COVID-19 vaccine iNNCOVACC launched

New Delhi: Union Health Minister Mansukh Mandaviya on Thursday unveiled the COVID-19 vaccine, iNNCOVACC in the presence of Union Minister of State (IC) for Science and Technology, Jitendra Singh. iNNCOVACC is the world’s first intranasal Covid-19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster dose. It is developed by Bharat Biotech International Limited (BBIL) in collaboration with Biotechnology Industry Research Assistance Council (BIRAC), a

World’s 1st Intranasal Covid vax from Bharat Biotech gets CDSCO approval

Hyderabad: Leading vaccine maker, Bharat Biotech International Limited (BBIL) on Monday announced that world’s first intranasal vaccine for Covid-19, iNCOVACC (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO) under Restricted Use in Emergency Situation for ages 18 and above, in India, for heterologous booster doses. iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised SARS-CoV-2 spike protein. This vaccine candidate was evaluated